Andi Roy
@roylab-oxford.bsky.social did:plc:6wi2ynttkmi7qt2ulmq2knhi
Clinician Scientist and Professor of Paediatric Haematology at University of Oxford. Childhood Leukaemia Research Group, Oxford: Developmental haematopoiesis and leukaemia https://www.paediatrics.ox.ac.uk/research/paediatric-leukaemia-research-group
Sur Bluesky depuis le
- Abonnés
- 281
- Abonnements
- 205
- Posts
- 71
- Jours dans les classements
- 0
Résumé
Andi Roy (@roylab-oxford.bsky.social) est sur Bluesky depuis le 15 novembre 2024. Le compte a 281 abonnés, suit 205 comptes et a publié 71 posts.
Présence dans les classements
Les meilleurs jours où les posts de ce compte sont entrés dans le top quotidien de Debya.
Ce compte n’est encore apparu dans aucun classement quotidien.
Posts aimés récemment
J’aime publics du réseau Bluesky.
New publication from the groups of Duncan Odom, Marieke Essers and myself: Concentrating cell-type-specific transcriptional signatures in bone marrow from interspecies comparisons: Cell Genomics www.cell.com/cell-genomic... @dkfz.bsky.social
Voir le postCongratulations to Professor Beth Psaila, who has received the 2026 Janet Rowley Award from the International Society for Experimental Hematology! https://www.imm.ox.ac.uk/news/psaila-2026-iseh-janet-rowley-award @rdm.ox.ac.uk @medsci.ox.ac.uk @ox.ac.uk
Voir le post🚨Two complementary preprints from our group reveal convergent mechanisms of inherited B-ALL predisposition. Check out this terrific work led by @larawahlster.bsky.social, @alneehus.bsky.social & #AndrewLee! www.biorxiv.org/content/10.6... www.biorxiv.org/content/10.6...
Voir le post🙏 Deeply honored to receive the 2026 Warren Alpert Prize! This award reflects the work by so many to enable transformative therapies for sickle cell disease and thalassemia, and the power of human genetics to reveal biology and guide new treatments! hms.harvard.edu/news/2026-wa...
Voir le postWe're proud to share that Blood has a JIF of 23.9 and continues its position as the most-cited journal in hematology, with 168,805 total citations in 2025. Blood Advances' JIF is 7.7. With 26,750 citations in 2025, it's among the top ten most cited hematology journals. #JCR2026
Voir le post
Comptes bloqués
Sur Bluesky, les blocages sont publics.
Ce compte ne bloque personne.